PPARG and metabolic dysfunction-associated steatotic liver disease: Genetic modelling and haplotype analysis of the two PPARG variants showed that patients with both minor alleles (GT) had a lower risk of NAFLD, but also increased inflammation and advanced fibrotic change, when compared with patients with both major alleles (CC).